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Pituitary homeobox 2 (PITX2) is a homeodomain transcription factor that has a substantial role in
cell proliferation and differentiation in various tissues. In this report, we have conducted a system-
atic study, using proteomic and genomic approaches, to characterize PITX2-interacting proteins and
PITX2-regulating genes. We identiﬁed four novel PITX2-associated protein partners Y box binding
factor-1, heterogeneous ribonucleoprotein K, nucleolin and heterogeneous nuclear ribonucleopro-
tein U in mass spectrometry analysis. We also found that overexpression of PITX2 upregulated 868
genes (2–25-fold) and downregulated 191 genes (2–15-fold) in DNA microarray analysis. These data
provide an insightful perspective for further studying PITX2 function and mechanism of action.
Structured summary:
MINT-6823857: PITX2 (uniprotkb:Q99697) physically interacts (MI:0218) with hnRNP K (uni-
protkb:P61978), YB-1 (uniprotkb:P67809), Nucleolin (uniprotkb:P19338) and hnRNP U (uni-
protkb:Q00839) by anti tag coimmunoprecipitation (MI:0007)
MINT-6823877: PITX2 (uniprotkb:Q99697) physically interacts (MI:0218) with beta catenin (uni-
protkb:P35222), hnRNP U (uniprotkb:Q00839), Nucleolin (uniprotkb:P19338), YB-1 (uniprotkb:P67809)
and hnRNP K (uniprotkb:P61978) by anti tag coimmunoprecipitation (MI:0007)
MINT-6823902: YB-1 (uniprotkb:P67809) physically interacts (MI:0218) with PITX2 (uniprotkb:Q99697)
by anti bait coimmunoprecipitation (MI:0006)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Transcription factor pituitary homeobox 2 (PITX2) is a member
of the homeobox gene family. A number of studies have demon-
strated that PITX2 has a diverse role in cell proliferation, differen-
tiation, hematopoiesis and organogenesis [1–4]. During early
embryogenesis, PITX2 is a key regulator in the establishment of
embryo left-right asymmetry [5]. In response to Wnt and other
growth factors, PITX2 regulates cell-type speciﬁc cell proliferationchemical Societies. Published by E
-1, Y box binding factor-1;
U; hnRNP K, heterogeneous
17, high mobility group-17;
ydroxylase
iological Sciences, One John
25755, USA. Fax: +1 304 696during the development of cardiac outﬂow tract [3]. Mutations of
PITX2 have been identiﬁed in several human disorders, such as
Axenfeld–Rieger syndrome, iridogoniodysgenesis syndrome and
sporadic Peter syndrome [6,7]. Pitx2-deﬁcient mice are embryonic
lethal and show severe defects in heart, eye, pituitary gland and
tooth organogenesis [3]. Previous studies have shown that PITX2
cooperates with b-catenin and LEF/TCF and thus regulates cell
proliferation by directly activating transcription of cyclin Ds and
c-myc [3,8,9]. Besides b-catenin and LEF/TCF, other functional
binding partners of PITX2, such as nuclear factor-1 (NF-1), high
mobility group-17 (HMG-17), MEF2A, Pit-1 and glial cells missing
a (GcMa), have also been reported [1,10–13].
In this study, we analyzed the co-immunoprecipitated protein
complex of PITX2 by mass spectrometry and successfully identiﬁed
four proteins, Y box binding factor-1 (YB-1), nucleolin, heteroge-
neous ribonucleoprotein K (hnRNP K) and heterogeneous nuclear
ribonucleoprotein U (hnRNP U), as novel PITX2-interactinglsevier B.V. All rights reserved.
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examining gene expression proﬁle of HEK293 cells with transient
overexpression of PITX2. Our result indicated that 868 genes and
191 genes were upregulated and downregulated more than
twofold, respectively. Many of these regulated genes have previ-
ously been linked to cell proliferation, cell differentiation, and
organogenesis of muscle and eye. Taken together, our ﬁndings pro-
vide an insightful perspective on PITX2 function and related molec-
ular mechanism.2. Materials and methods
2.1. Cell culture
HEK293 cells were obtained from American Type Culture Col-
lection (ATCC, Rockville, MD) and cultured in Dulbecco’s modiﬁed
Eagle’s medium with 4.5 g/l glucose, 10% fetal bovine serum, and
penicillin-streptomycin (100 IU/ml) at 37 C in a humidiﬁed atmo-
sphere with 5% CO2.2.2. Immunoprecipitation and immunoblotting
The open reading frame of human PITX2c, along with a FLAG
epitope insertedbetweenMet1andAsn2,wasampliﬁedbyPCRwith
the following primers: forward primer (50-ACTGaagcttgccaccATG-
GATTACAAGGATGACGACGATAAGAACTGCATGAAAGGCCCGCTTCA-
C-30, HindIII and Kozak site in lowercase) and reverse primer
(50-AGCTggtacctcaCACGGGCCGGTCCACTG-30, KpnI site and stop co-
don in lowercase). The PCR productwas cloned into theHindIII/KpnI
sites of the vector pEGFP-N1 (Clontech). The resulting construct
pEGFP-NFLAG-PITX2c, along with the control vector pEGFP-N1,
was transfected into HEK293 cells using FugeneHD transfection re-
agent (Roche). The cells were observed 24 and 48 h post-transfec-
tion, and no signiﬁcant difference of cell growth and cell viability
was noticed between the test and control groups. Cells were then
lysed in immunoprecipitation buffer (50 mM Tris–HCl pH 7.4,
150 mM NaCl, 5 mM EDTA, 1% Triton X-100) after 48 h of initial
transfection. For nuclear protein extraction, cells were incubated
in hypotonic buffer (10 mM HEPES, 10 mM KCl, 1.5 mM MgCl2,
0.5 mM DTT) for 10 min before adding of 0.5% CA-630. Cell nuclei
were then isolated by centrifugation. Nuclear proteins were ex-
tracted by the immunoprecipitation buffer. Cell lysates were pre-
clearedbyproteinGbeads (Pierce) for2 hat 4 C, and then incubated
with anti-FLAGM2conjugated-agarose beads (Sigma) or rabbit anti-
YB-1 (Epitomics) for 2 h or overnight at 4 C. The beadswerewashed
ﬁve times using the immunoprecipitation buffer. To eliminate indi-
rect protein–protein interactions, protein complexes were washed
by consecutive addition of 2% and 4% Triton X-100 solutions.
Washed beads were boiled in reducing SDS loading buffer for
10 min to elute proteins, which were then subjected to mass spec-
trometry and immunoblotting. Immunoblotting was performed as
described previously [16]. Primary antibodies were mouse anti-
PITX2 (Abnova), rabbit anti-b catenin and anti-YB-1 (Cell Signaling),
rabbit anti-hnRNP K (Epitomics), rabbit anti-nucleolin and anti-
hnRNP U (Abcam).
2.3. Peptide mass ﬁngerprinting and LC-MALDI mass spectrometry
Proteins in the PITX2-immunoprecipitated complex were sepa-
rated by SDS–PAGE and silver stained. Protein bands with high
abundance were excised and analyzed by LC-MALDI (ABI Tempo
LC-MALDI) and MALDI MS/MS (ABI 4800 MALDI TOF/TOF) mass
spectrometry analysis by Protea Bioscience (WV, USA). Peptides
were identiﬁed by performing Mascot MS/MS Ion search (maxi-mum missed cleavages: 2; peptide mass tolerance: ±1–2 Da; frag-
ment mass tolerance: ±0.8–1 Da) on the non-redundant fasta
database obtained from the National Center for Biotechnology
Information (NCBI) and Swissprot database. The peptides and
proteins with signiﬁcant Mowse score (P < 0.05), except trypsins,
were reported.
2.4. RNA preparation
HEK293 cells were transiently transfected with pEGFP-NFLAG-
PITX2c or pEGFP-N1. Forty eight hours after transfection, cells were
harvested for total RNA extraction by using TRI Reagent (Ambion).
RNA quality was assessed by electrophoretic analysis on an Agilent
Model 2100 Bioanalyzer. All RNA samples used in this study had
RNA Integrity Numbers greater than 8.0.
2.5. Microarray analysis
We employed a balanced block design with dye swap using four
biological replicates from HEK293 cells transfected with either
pEGFP-N1 or pEGFP-NFLAG-PITX2c. For microarray probes, total
RNA (250 ng) was used as the template for synthesis of internally
labeled cRNAs using Agilent QuickAmp Labeling kit and cyanine
3-CTP and cyanine 5-CTP (Perkin–Elmer, Waltham, MA) and a
modiﬁed QuickAmp protocol [14]. A total of 825 ng of cyanine 3-
and cyanine5-labeled cRNAs was combined and hybridized onto
Agilent Whole Human Genome 4  44 K microarrays at 65 C for
17 h and then washed according to the manufacturer’s protocol.
Slides were scanned on Agilent DNA Microarray Scanner.
2.6. Statistical analysis of microarray data
Data were lowess-normalized and extracted from arrays using
Agilent Feature Extraction v9.5. Features for which both channels
had low signal were excluded. Log2 expression ratios of PITX2-
overexpressed to control samples were imported to the Multiple
Experiment Viewer (MeV) v4.0 to perform statistical analysis
[15]. Values were compared for signiﬁcant deviation from zero
using one-class Signiﬁcance Analysis of Microarrays (SAM) [16].
Only probes for which at least three replicates passed the low sig-
nal ﬁlter were included. SAM was performed with the maximum
number of unique permutation, and delta was chosen to give 0% re-
ported 90th percentile False Discovery Rate (FDR). Data for signif-
icantly differentially expressed genes are shown in Supplementary
Table 1. Raw data from the microarray experiment are available at
the NCBI Gene Expression Omnibus with Accession No. GSE13216.
2.7. Semi-quantitative RT-PCR analysis
To validate microarray data, we performed semi-quantitative
RT-PCR. The cDNAs were reverse transcribed from total RNA in
the presence of random primers (Clontech), and used as templates
in the PCR under the following parameters: 94 C for 2 min, 1 cy-
cle; 94 C for 20 s, 56 C for 20 s (58 C for FOXJ1 and H19), 72 C
for 2 min, 32 cycles; followed by a 6-min extension at 72 C. The
primers used for this study are listed in Supplementary Table 2.3. Results
3.1. Identiﬁcation of novel PITX2-associated proteins
Despite the substantial role of PITX2 in cell proliferation and
differentiation, the molecular mechanism underlying PITX2 action
is still limited. Identifying novel PITX2-interacting protein partners
would further our understanding of how PITX2 works. To do so, we
Fig. 1. (A) PITX2 was transiently overexpressed in HEK293 cells. The cell lysates
from pEGFP-N1 and pEGFP-NFLAG-PITX2c were analyzed by immunoblotting. (B)
YB-1, hnRNP K, nucleolin, hnRNP U and b-catenin are PITX2-interacting proteins.
The PITX2-immunoprecipitated complex, along with the protein samples equiva-
lent to 10% input, was probed with respective antibodies. (C) The endogenous
protein complex of YB-1 and PITX2 was immunoprecipitated from HEK293 nuclear
lysates by an YB-1 antibody and then detected by a PITX2 antibody.
Table 2
Exempliﬁed genes regulated by PITX2.
Accession No. Gene
name
Fold Description
Proliferation
NR_002196 H19 12.0 Imprinted maternally expressed untranslated
mRNA (H19) on chromosome 11
NM_003914 CCNA1 11.6 Cyclin A1, cell cycle regulator
NM_003933 BAIAP3 7.7 BAI1-associated protein 3
NM_001007139 IGF2 5.5 Insulin-like growth factor 2 (somatomedin A)
NM_020975 RET 5.4 Ret proto-oncogene
NM_032043 BRIP1 0.17 BRCA1 interacting protein C-terminal helicase
1
NM_004407 DMP1 0.16 Dentin matrix acidic phosphoprotein
Muscle
NM_004933 CDH15 9.5 Cadherin 15, M-cadherin (myotubule)
NM_000257 MYH7 6.0 Myosin, heavy chain 7, cardiac muscle, beta
AB002384 C6orf32 4.6 mRNA for KIAA0386 gene
Eye
NM_014279 OLFM 9.1 Olfactomedin 1
NM_000283 PDE6B 8.9 Phosphodiesterase 6B, cGMP-speciﬁc, rod,
beta (congenital stationary night blindness 3,
autosomal dominant)
NM_014421 DKK2 6.1 Dickkopf homolog 2
NM_000327 ROM1 3.9 Retinal outer segment membrane protein 1
Development/differentiation
NM_032784 RSPO3 20.5 R-spondin 3 homolog
NM_000582 SPP1 9.5 Secreted phosphoprotein 1 (osteopontin, bone
sialoprotein I, early T-lymphocyte activation
1)
NM_001454 FOXJ1 7.5 Forkhead box J1
NM_030761 WNT4 6.8 Wingless-type MMTV integration site family,
member 4
Others
NM_001346 DGKG 9.0 Diacylglycerol kinase, gamma 90 kDa
NM_182908 DHRS2 25.2 Dehydrogenase/reductase (SDR family)
member 2
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then co-immunoprecipitated PITX2 and its associated protein com-
plex from the cell lysates. After the protein complex was separated
by SDS–PAGE, ﬁve protein bands with high abundance, which did
not appear in the pEGFP-N1 control sample (data not shown), were
excised and subjected to mass spectrometry analysis. In addition to
PITX2, four novel PITX2-associated proteins, YB-1, hnRNP K, nucle-
olin and hnRNP U, were identiﬁed from each protein band, respec-
tively (Table 1). These four proteins achieved the highest
signiﬁcant scores among other candidates and their molecular
weights matched the PAGE-determined molecular weights. To fur-
ther conﬁrm the association of these four proteins with PITX2, we
performed immunoblotting on PITX2-immunoprecipitated pro-Table 1
List of proteins identiﬁed from the PITX2-immunoprecipitated complex, as described in
homology (P < 0.05).
Protein Peptides (ions
Heterogeneous nuclear ribonucleoprotein U (hnRNP U) (R) NFILDQTN
(R) GYFEYIEE
(K) SSGPTSLF
Nucleolin (K) EVFEDAAE
(K) GFGFVDFN
(K) GLSEDTTE
Heterogeneous nuclear ribonucleoprotein K (hnRNP K) (R) NLPLPPPP
Y box binding protein-1 (YB-1) (R) NEGSESAP
(R) NGYGFINR
Pituitary homeobox 2 (PITX2) (R) EEIAVWTN
(R) THFTSQQLteins. As shown in Fig. 1B, we indeed detected YB-1, hnRNP K,
nucleolin and hnRNP U in the PITX2-immunoprecipitated protein
complex. As a positive control for the PITX2 complex, we also dem-
onstrated the presence of b-catenin, a previously reported binding
partner of PITX2 (Fig. 1B). Using an YB-1 antibody, we also detected
the interaction of PITX2 and YB-1 at endogenous levels (Fig. 1C).
We were not able to test for interactions between PITX2 and other
novel binding partners since immunoprecipitation-suitable anti-
bodies for these proteins are not currently available.
3.2. Identiﬁcation of PITX2-regulated genes
Since PITX2 has been shown to participate in a number of
physiological processes, we hypothesized that PITX2 may haveMaterials and methods. Proteins with ions scores >32 indicate identity or extensive
score) RefSeq No. Gel region
VSAAAQR (123) NP_114032.2 100–120 kDa
NKYSR (16)
AVTVAPPGAR (50)
IR (27) NP_005372.2 80–100 kDa
SEEDAK (16)
ETLKESFDGS (17)
PPR (43) NP_002131.2 60–70 kDa
EGQAQQR (49) NP_004550.2 40–50 kDa
(59)
LTEAR (58) NP_700476.1 30–40 kDa
QELEATFQR (53)
Fig. 2. Semi-quantitative RT-PCR analysis of PITX2-regulating genes. Actin was used as an internal control. Vector = pEGFP-N1; PITX2 = pEGFP-NFLAG-PITX2c.
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microarray to examine the gene expression proﬁle of HEK293 cells
transiently overexpressing PITX2 compared to cells with normal
PITX2 levels. Remarkably, we found that 868 genes and 191 genes
were upregulated and downregulated, respectively, by more than
twofold. Many of these regulated genes can be clustered into dif-
ferent biological processes, such as cell proliferation, cell differen-
tiation, and organogenesis of muscle and eye, as exempliﬁed in
Table 2. A more comprehensive Gene Ontology (GO) analysis is
provided in Supplementary Table 3. To verify microarray data,
we used semi-quantitative RT-PCR to measure relative changes in
the mRNA abundance of twelve genes. The RT-PCR results were
very consistent with the microarray results (Fig. 2).4. Discussion
In this study, we have identiﬁed YB-1, nucleolin, hnRNP K and
hnRNP U as the novel PITX2-interacting partners. The four proteins
show consistency in terms of their functions in that all of them
play roles in regulating cell proliferation and RNA processing
[17–20]. YB-1 is a multifunctional protein that functions in the reg-
ulation of cell proliferation and drug resistance [21]. Nuclear YB-1
acts as a transcription factor which controls transcription of genes
involved in cell proliferation, such as cyclin A [17,22]. In this re-
gard, our two observations, upregulation of cyclin A upon overex-
pression of PITX2 and the association of YB-1 and PITX2, may well
echo each other. YB-1 also can bind to mRNA and become part of
messenger ribonucleoprotein particels (mRNPs), thus controls
gene translation [21]. Nucleolin is a ubiquitously expressed protein
and a major component of the nucleolus [18]. Nucleolin functions
include chromatin-remodeling, regulation of mRNA processing,
ribosome assembly and nucleo-cytoplasmic transport [18]. Nucle-
olin, hnRNP K and YB-1 have been previously reported to be
assembled into a macromolecular complex regulating mRNA
stability [23,24]. In this respect, it is tempting to postulate that
PITX2, through association with YB-1, may regulate mRNA stability
as well. Indeed, such function has been previously assigned to
PITX2 [25]. The identiﬁcation of novel PITX2-interacting partners
provides a new look at the mechanistic aspect of PITX2 function.
It also suggests that PITX2 may regulate its downstream targets
at both transcription and translation levels. Hence, the functional
implication of this novel PITX2-interacting network will be a valu-
able topic in future studies.
Previously, only a few PITX2 transcription targets have been
identiﬁed, such as cyclin Ds, LEF and procollagen lysyl hydroxylase
(PLOD) [3,9,26,27]. However, these target genes may not be capa-ble of mediating all functions of PITX2. In this study, we have found
a remarkable set of potential target genes of PITX2. Of these candi-
dates, FOXJ1 and DKK2 have been reported as direct targets of
PITX2 transcriptional regulation in two recently published studies
[28,29], consistent with our ﬁndings. To this end, we cannot rule
out the possibility that some of the genes detected in our expres-
sion proﬁle study are not directly regulated by PITX2. Nonetheless,
our map of the PITX2-regulated gene network opens new avenues
for studying biological processes involving PITX2.
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